Table 1.
Patient demographics.
| NK1 group | ONS group | |
|---|---|---|
| Patients | n = 82 | n = 89 |
| Age, years | 57 ± 14 | 56 ± 13 |
| Height, cm | 154 ± 8 | 155 ± 6 |
| Weight, kg | 57 ± 11 | 56 ± 10 |
| ASA PS I/II/III | 23/58/1 | 27/61/1 |
| PONV risk factors | ||
| Nonsmoker (n) | 80 | 88 |
| History of motion sickness (n) | 26 | 22 |
| Women (n) | 82 | 89 |
| Postoperative opioids, µg | 470 ± 449 | 443 ± 451 |
| Duration of anesthesia, min | 269 ± 124 | 280 ± 138 |
| Duration of surgery, min | 209 ± 113 | 219 ± 129 |
| Anesthetics; remifentanil, mg | 3.4 ± 2.4 | 3.2 ± 3.2 |
| Blood loss, ml | 321 ± 488 | 251 ± 360 |
| Fluid volume, ml | 2245 ± 1312 | 2127 ± 1101 |
Data are presented as means ± SD (or range) or number of patients; NK1 group, i.v. fosaprepitant; ONS group, i.v. ondansetron; PONV, postoperative nausea and vomiting; ASA PS, American Society of Anesthesiologists physical status.